Raymond James & Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.13M | Sell |
20,266
-399
| -2% | -$22.2K | ﹤0.01% | 2608 |
|
|
2024
Q2 | $849K | Buy |
20,665
+144
| +0.7% | +$5.92K | ﹤0.01% | 2721 |
|
|
2024
Q1 | $958K | Buy |
20,521
+5,766
| +39% | +$269K | ﹤0.01% | 2609 |
|
|
2023
Q4 | $706K | Sell |
14,755
-2,991
| -17% | -$143K | ﹤0.01% | 2718 |
|
|
2023
Q3 | $633K | Sell |
17,746
-9,055
| -34% | -$323K | ﹤0.01% | 2725 |
|
|
2023
Q2 | $1.24M | Buy |
26,801
+2,733
| +11% | +$126K | ﹤0.01% | 2337 |
|
|
2023
Q1 | $965K | Buy |
24,068
+4,234
| +21% | +$170K | ﹤0.01% | 2453 |
|
|
2022
Q4 | $919K | Buy |
19,834
+8,990
| +83% | +$417K | ﹤0.01% | 2474 |
|
|
2022
Q3 | $449K | Sell |
10,844
-2,662
| -20% | -$110K | ﹤0.01% | 2927 |
|
|
2022
Q2 | $806K | Sell |
13,506
-376
| -3% | -$22.4K | ﹤0.01% | 2586 |
|
|
2022
Q1 | $1.01M | Buy |
13,882
+4,373
| +46% | +$318K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $800K | Sell |
9,509
-329
| -3% | -$27.7K | ﹤0.01% | 2769 |
|
|
2021
Q3 | $887K | Buy |
9,838
+397
| +4% | +$35.8K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $900K | Sell |
9,441
-6,277
| -40% | -$598K | ﹤0.01% | 2655 |
|
|
2021
Q1 | $1.79M | Buy |
15,718
+5,990
| +62% | +$682K | ﹤0.01% | 2090 |
|
|
2020
Q4 | $1.35M | Buy |
9,728
+3,612
| +59% | +$500K | ﹤0.01% | 2133 |
|
|
2020
Q3 | $503K | Buy |
6,116
+278
| +5% | +$22.9K | ﹤0.01% | 2606 |
|
|
2020
Q2 | $457K | Buy |
+5,838
| New | +$457K | ﹤0.01% | 2633 |
|
|
2018
Q2 | – | Sell |
-5,231
| Closed | -$267K | – | 3516 |
|
|
2018
Q1 | $267K | Sell |
5,231
-1,140
| -18% | -$58.2K | ﹤0.01% | 2946 |
|
|
2017
Q4 | $295K | Sell |
6,371
-877
| -12% | -$40.6K | ﹤0.01% | 2825 |
|
|
2017
Q3 | $386K | Buy |
7,248
+138
| +2% | +$7.35K | ﹤0.01% | 2619 |
|
|
2017
Q2 | $442K | Buy |
7,110
+1,812
| +34% | +$113K | ﹤0.01% | 2487 |
|
|
2017
Q1 | $359K | Sell |
5,298
-177
| -3% | -$12K | ﹤0.01% | 2577 |
|
|
2016
Q4 | $385K | Sell |
5,475
-6,403
| -54% | -$450K | ﹤0.01% | 2483 |
|
|
2016
Q3 | $843K | Buy |
11,878
+7,129
| +150% | +$506K | ﹤0.01% | 1980 |
|
|
2016
Q2 | $232K | Sell |
4,749
-6,242
| -57% | -$305K | ﹤0.01% | 2559 |
|
|
2016
Q1 | $696K | Buy |
+10,991
| New | +$696K | ﹤0.01% | 1862 |
|